Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN73579020Phase 2Completed
Phase 2, randomised trial in pulmonary sarcoidosis comparing Bosentan with Placebo (2 arms). Primary endpoints: Safety, Overall response rate and 1 more. Started Oct 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN73579020.